Cresco Labs Inc.
Income Statement
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Revenue | $655.8M | $724.3M | $770.9M | $842.7M | $821.7M | $476.3M | $128.5M |
| Cost of Revenue | $331.3M | $359.9M | $408.5M | $435.7M | $415.3M | $269.6M | $82.9M |
| Gross Profit | $324.6M | $364.5M | $362.4M | $407.0M | $406.3M | $206.7M | $45.6M |
| Gross Margin | 49.5% | 50.3% | 47.0% | 48.3% | 49.5% | 43.4% | 35.5% |
| Operating Expenses | |||||||
| Research & Development | — | — | — | — | — | — | — |
| SG&A Expense | $247.5M | $254.8M | $299.2M | — | — | — | — |
| Operating Income | $-28.0M | $107.3M | $-87.8M | $-84.3M | $-217.4M | $-23.5M | $-34.3M |
| Operating Margin | -4.3% | 14.8% | -11.4% | -10.0% | -26.5% | -4.9% | -26.7% |
| Interest Expense | $41.7M | $37.9M | $43.6M | $57.8M | $51.2M | $31.2M | $7.9M |
| Pretax Income | $-95.4M | $-10.6M | $-146.9M | $-126.9M | $-256.7M | $-64.2M | $-50.8M |
| Income Tax Expense | $44.6M | $49.9M | $33.0M | $88.9M | $40.1M | $28.6M | $14.5M |
| Net Income | $-135.4M | $-74.4M | $-175.5M | $-212.0M | $-319.6M | $-102.2M | $-43.2M |
| Net Margin | -20.6% | -10.3% | -22.8% | -25.2% | -38.9% | -21.5% | -33.6% |
| EPS (Basic) | $-0.38 | $-0.22 | $-0.54 | $-0.71 | $-1.22 | $-0.39 | $-0.37 |
| EPS (Diluted) | $-0.38 | $-0.22 | $-0.54 | $-0.71 | $-1.22 | $-0.39 | $-0.37 |
| Shares Outstanding (Basic) | 355.0M | 345.5M | 323.8M | — | — | — | — |
| Shares Outstanding (Diluted) | 355.0M | 345.5M | 323.8M | — | — | — | — |
| Dividends Per Share | — | — | — | — | — | — | — |